Johnson & Johnson has stopped the trial of its coronavirus vaccine candidate after an unexplained illness in one of the participants, although it was not immediately clear whether the person was part of the trial (or experimental group) receiving the injection, or the control group that does not (people in …
Read More »Covid-19: Results of phase three of the Oxford vaccine for November-December | India News
NEW DELHI: Results from phase three trials of the Oxford-AstraZeneca vaccine underway in India could be available in “late November-early December”, raising hopes that the leading candidate anti-Covid, made in India by the Serum Institute – may be available sooner than expected. The government’s vision of a possible timeline came …
Read More »AstraZeneca and Johnson & Johnson: 2 Major Covid-19 Vaccine Trial Stops Seen World
An advanced-stage study of Johnson & Johnson’s (J&J) Covid-19 candidate vaccine was suspended Monday after it allegedly had an adverse effect on a participant. The participant’s “unexplained illness” is being investigated by the company and a statement was issued on Monday. Accidents and other so-called adverse events “are an expected …
Read More »‘Normality only when the second generation of the Covid-19 vaccine is out’: Bill Gates
Microsoft co-founder Bill Gates has given a grim picture to the world seeking to return to normal after being hit by the coronavirus pandemic. On a television show, the billionaire said that life will return to normal only when a second generation of the Covid-19 vaccine becomes available. Gates told …
Read More »Coronavirus Vaccine News: Inhaled Vaccines Aim to Fight Coronavirus at Its Point of Attack |
The Covid-19 vaccines closest to the finish line are designed to be injected into the arm. Researchers are looking at whether they can get better protection from vaccines that fight the virus at its point of attack – the nose and mouth. Most vaccines in human trials require two injections …
Read More »Inhaled vaccines aim to combat the coronavirus at its point of attack
The Covid-19 vaccines closest to the finish line are designed to be injected into the arm. Researchers are looking at whether they can get better protection from vaccines that fight the virus at its point of attack – the nose and mouth. Most vaccines in human trials require two injections …
Read More »India expects to vaccinate 20-25 million million people by July next year
By: Desk Explained | Pune | Updated: October 6, 2020 9:21:50 am Travelers wearing masks wait at a traffic intersection in Kochi, Kerala (AP) Coronavirus Vaccine Tracker: India is working to vaccinate 20 to 25 million million of its population, about one sixth of its total population, against Covid19 disease …
Read More »The government plans to administer covid-19 vaccines at 20-25 crore Indians for July
NEW DELHI: The government plans to administer around 40-50 crore of covid-19 vaccines to 20-25 crore of Indians in July. The Center, together with the states, is also preparing a list of priority population groups, especially front-line health workers, who would receive vaccines, Union Health Minister Harsh Vardhan said on …
Read More »Don’t hope for a Covid-19 vaccine. It may be a two year wait
An effective vaccine may be the only real protection against Covid-19 as it stands, but don’t pin your hopes on getting it anytime soon. As India’s death toll from Covid surpasses one lakh, knowledge from the scientific community and government officials suggest that it could take up to two years …
Read More »Oxford University COVID-19 Vaccine in Six Months: Report
The UK National Health Service is preparing for mass vaccination (Representational) London: A coronavirus vaccine, jointly developed by scientists at the University of Oxford and the pharmaceutical giant AstraZeneca, may be approved by health regulators later this year, according to a report by UK media. The candidate vaccine is the …
Read More »